Next 10 |
home / stock / mtem / mtem articles
AUSTIN, Texas, March 28, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (NASDAQ:MTEM, "Molecular Templates, " or "MTEM")), a clinical-stage...
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, whic...
AUSTIN, Texas, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc.?(NASDAQ:MTEM, "Molecular Templates, " or "MTEM")), a clinical-stage...
AUSTIN, Texas, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (NASDAQ:MTEM, "Molecular Templates, " or "MTEM")), a clinical-stage ...
Jonathan Lanfear, Board Member at Molecular Templates (NASDAQ:MTEM), reported a large acquisition of company stock options on October 31, according...
Corazon D. Sanders, Board Member at Molecular Templates (NASDAQ:MTEM), reported a large acquisition of company stock options on October 31, accordi...
Gabriela Gruia, Director at Molecular Templates (NASDAQ:MTEM), reported a large acquisition of company stock options on October 31, according to a ...
Kevin M Lalande, Director at Molecular Templates (NASDAQ:MTEM), reported a large acquisition of company stock options on October 31, according to a...
AUSTIN, Texas, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (NASDAQ:MTEM, "Molecular Templates, " or "MTEM")), a clinical-stage ...
News, Short Squeeze, Breakout and More Instantly...
Molecular Templates Inc. Company Name:
MTEM Stock Symbol:
NASDAQ Market:
Molecular Templates Inc. Website:
AUSTIN, Texas, March 28, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (NASDAQ:MTEM, "Molecular Templates, " or "MTEM")), a clinical-stage...
AUSTIN, Texas, March 28, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, known a...
Molecular Templates, Inc. (NASDAQ: MTEM) is one of today's top gainers. The company's shares have moved 25.97% on the day to $2.33. Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of canc...